This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. Injectable weight loss medications — also ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

MUMBAI, India and WARREN, N.J., Feb. 27, 2026 /PRNewswire/ -- Cipla USA Inc. the wholly owned subsidiary of Cipla Limited(BSE: 500087; NSE: CIPLA; and hereafter referred to as "Cipla") today announced ...

Teva Pharmaceutical Industries Ltd ADR (NYSE:TEVA) saw its stock climb 2.7% after announcing FDA approval and the U.S. launch ...

Liraglutide lowered body mass, slowed weight gain and improved health markers in kids ages 6 through 11, according to research presented Tuesday at a medical conference and published in the New ...

Weight loss injections are medications that help the user lose weight. These drugs have been increasing in popularity over the last few years, thanks to a combination of their effectiveness and ...

WEIGHT loss jabs like Mounjaro and Wegovy are known to cause side effects like stomach pain and vomiting. But in some cases, these ‘typical’ symptoms could be signs of serious ...

The FDA approved the first-ever generic form of a GLP-1 receptor agonist specifically indicated for weight loss, Teva Pharmaceuticals announced Thursday. The generic form of liraglutide (Saxenda) is ...

OVER 200 deaths linked to the blockbuster weight loss jabs Mounjaro and Wegovy have now been reported. There have also been 15,000 reports of “serious” adverse effects to the fat jabs, ...

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...